Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Olodaterol (Striverdi Respimat) (BI 1744)
print preview
bookmark
share with colleague
General Information
Company
Boehringer Ingelheim GmbH
Description
Long-acting beta 2 agonist (LABA)
Molecular Target
Adrenergic receptor beta 2 (ADRB2)
Mechanism of Action
Latest Stage of Development
Registration
Indication
Chronic obstructive pulmonary disease (COPD)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information